Strain-dependent effects of phenobarbital on liver tumor promotion in inbred mice
- PMID: 2179966
Strain-dependent effects of phenobarbital on liver tumor promotion in inbred mice
Abstract
Inbred strains of mice were found to differ significantly in their susceptibility to liver tumor promotion by PB. The susceptibility to promotion of hepatocarcinogenesis by this drug was a dominant trait in crosses between the sensitive DBA and resistant C57 mice. The reciprocal F1 hybrids responded similarly to tumor promotion by PB. PB promoted the development of hepatoblastomas in D2B6F1 males but not in B6D2F1 mice. Female mice of the D2B6F1 cross, similarly exposed to PB, failed to develop hepatoblastomas. These results suggested a sex-linked differential response to the development of hepatoblastomas in reciprocal F1 hybrids that are genetically identical except for the reverse origin of their X and Y chromosomes. Differences in the promoting effects of PB between C57 and DBA mice appeared to correlate with differences in the metabolism/detoxification of this drug. In conclusion, mouse strains that differ in susceptibility to two-stage liver carcinogenesis provide excellent opportunities to investigate the genetic and/or biochemical mechanisms responsible for these differences. Understanding these mechanisms may lead to the identification of factors that affect liver tumor development not only in mice but in other species as well.
Similar articles
-
Promotion of malignant 'embryonal' liver tumors by phenobarbital: increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6)F1 mice initiated with N-nitrosodiethylamine.Carcinogenesis. 1989 Jul;10(7):1345-8. doi: 10.1093/carcin/10.7.1345. Carcinogenesis. 1989. PMID: 2472233
-
Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice.Carcinogenesis. 1986 Feb;7(2):215-20. doi: 10.1093/carcin/7.2.215. Carcinogenesis. 1986. PMID: 3948311
-
Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.Toxicol Sci. 2005 May;85(1):515-29. doi: 10.1093/toxsci/kfi129. Epub 2005 Feb 23. Toxicol Sci. 2005. PMID: 15728704
-
Genetic background and development of skin tumors.Carcinog Compr Surv. 1989;11:187-212. Carcinog Compr Surv. 1989. PMID: 2493334 Review.
-
Perinatal mouse liver carcinogenesis as a sensitive carcinogenesis model and the role of the sex hormonal environment in tumor development.Prog Clin Biol Res. 1990;331:53-68. Prog Clin Biol Res. 1990. PMID: 2179965 Review. No abstract available.
Cited by
-
Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.Mar Drugs. 2010 Jul 13;8(7):2129-41. doi: 10.3390/md8072129. Mar Drugs. 2010. PMID: 20714427 Free PMC article.
-
Mice deficient in glycerol-3-phosphate acyltransferase-1 have a reduced susceptibility to liver cancer.Toxicol Pathol. 2012 Apr;40(3):513-21. doi: 10.1177/0192623311432298. Epub 2012 Jan 3. Toxicol Pathol. 2012. PMID: 22215515 Free PMC article.
-
Progression of Hepatic Adenoma to Carcinoma in Ogg1 Mutant Mice Induced by Phenobarbital.Oxid Med Cell Longev. 2017;2017:8541064. doi: 10.1155/2017/8541064. Epub 2017 Jul 13. Oxid Med Cell Longev. 2017. PMID: 28785378 Free PMC article.
-
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.Cancer Cell. 2016 Dec 12;30(6):909-924. doi: 10.1016/j.ccell.2016.10.007. Epub 2016 Nov 23. Cancer Cell. 2016. PMID: 27889186 Free PMC article.
-
The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk.Nat Genet. 2020 Nov;52(11):1139-1143. doi: 10.1038/s41588-020-00727-5. Epub 2020 Oct 26. Nat Genet. 2020. PMID: 33106632 Free PMC article. Review.